7Baggers

Hims & Hers Health Quarterly Balance Sheets Chart

Quarterly
 | 
Annual
 
 Goodwill  
 Cash and Cash Eq  
 Account Payables  
 Deferred Revenue  
 Long-Term Debt  
 Inventory  
20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 20240331 20240630 20240930 20241231 20250331 20250630 00.160.320.480.640.80.961.12Billion

Hims & Hers Health Quarterly Balance Sheets Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 
                        
  assets                      
  current assets:                      
  cash and cash equivalents1,124,582,000 273,736,000 220,584,000 165,518,000 129,295,000 105,237,000 96,663,000 57,996,000 65,417,000 48,745,000 46,772,000 57,964,000 55,033,000 48,284,000 71,784,000 64,772,000 107,145,000 88,169,000 1,058,267 1,257,601   
  short-term investments20,033,000 48,935,000 79,667,000 88,553,000 97,997,000 98,355,000 124,318,000 154,501,000 127,725,000 135,648,000 132,853,000 140,427,000 139,944,000 154,769,000 175,490,000 187,653,000 210,178,000 235,097,000     
  inventory141,800,000 76,096,000 64,427,000 49,110,000 40,588,000 29,826,000 22,464,000 21,992,000 21,417,000 20,697,000 21,562,000 22,347,000 19,673,000 12,143,000 13,558,000 10,858,000 6,590,000 4,523,000     
  prepaid expenses and other current assets69,151,000 48,197,000 31,153,000 23,194,000 23,038,000 28,316,000 21,608,000 15,730,000 20,089,000 20,435,000 15,408,000 12,717,000 15,835,000 16,750,000 9,073,000 10,950,000 12,429,000 12,407,000     
  total current assets1,355,566,000 446,964,000 395,831,000 326,375,000 290,918,000 261,734,000 265,053,000 250,219,000 234,648,000 225,525,000 216,595,000 233,455,000 230,485,000 231,946,000 269,905,000 274,233,000 336,342,000 340,196,000 1,108,367 1,332,751 1,475,732 1,599,052 
  restricted cash368,000 1,223,000 856,000 856,000 856,000 856,000 856,000 856,000 856,000 856,000 856,000 856,000 856,000 856,000 856,000 856,000 856,000      
  goodwill117,753,000 117,753,000 112,728,000 112,728,000 110,881,000 110,881,000 110,881,000 110,881,000 110,881,000 110,881,000 110,881,000 110,881,000 110,881,000 110,881,000 110,881,000 110,881,000 2,739,000      
  property, equipment, and software205,480,000 155,707,000 82,083,000 52,144,000 49,540,000 45,212,000 36,143,000 28,238,000               
  intangible assets40,657,000 43,431,000 43,410,000 44,818,000 17,133,000 17,863,000 18,574,000                
  operating lease right-of-use assets71,661,000 62,198,000 10,881,000 10,884,000 11,034,000 11,422,000 9,588,000 4,302,000 4,735,000 4,548,000 4,936,000 5,318,000 4,459,000 4,787,000 5,111,000        
  deferred tax assets84,229,000 62,493,000 61,603,000 54,318,000                   
  other long-term assets1,868,000 1,942,000 147,000 138,000 138,000 138,000 91,000 72,000 18,802,000 13,587,000 11,232,000 10,227,000 9,478,000 8,721,000 7,942,000 7,167,000 7,762,000 4,848,000     
  total assets1,877,582,000 891,711,000 707,539,000 602,261,000 480,500,000 448,106,000 441,186,000 413,865,000 389,884,000 376,306,000 366,341,000 382,827,000 379,965,000 382,039,000 420,585,000 420,069,000 347,699,000 345,900,000 205,633,422 205,813,988 206,200,737 206,287,199 
  liabilities and stockholders' equity                      
  current liabilities:                      
  accounts payable105,009,000 108,919,000 91,180,000 75,444,000 57,099,000 43,919,000 43,070,000 42,001,000 38,267,000 37,609,000 32,363,000 32,972,000 27,093,000 23,906,000 19,640,000 16,094,000 15,564,000 13,233,000 48,194 24,713 21,656 74,554 
  accrued liabilities65,671,000 56,942,000 53,013,000 43,224,000 28,948,000 26,714,000 28,972,000 27,360,000 19,607,000 14,121,000 12,448,000 17,145,000 11,809,000 9,089,000 12,194,000 11,206,000 10,761,000 5,823,000     
  deferred revenue98,417,000 110,765,000 75,285,000 32,184,000 20,990,000 13,735,000 7,733,000 4,392,000 2,058,000 2,866,000 1,472,000 2,124,000 2,337,000 1,145,000 3,188,000 1,993,000 1,019,000 624,000     
  operating lease liabilities3,135,000 3,736,000 1,889,000 1,793,000 1,634,000 1,544,000 1,281,000 1,930,000 1,839,000 1,687,000 1,658,000 1,605,000 1,412,000 1,388,000 1,365,000        
  total current liabilities272,232,000 280,362,000 221,367,000 152,645,000 108,671,000 93,324,000 88,468,000 82,545,000 66,547,000 56,283,000 47,941,000 66,818,000 55,623,000 48,500,000 79,221,000 52,498,000 27,344,000 19,680,000 4,896,647 3,037,725 1,167,702 1,167,388 
  convertible senior notes969,467,000                      
  other long-term liabilities1,401,000 2,440,000   22,000 21,000 22,000 5,000 14,000 84,000 35,000 249,000 371,000 517,000 629,000 1,218,000 1,895,000      
  total liabilities1,314,886,000 342,450,000 230,823,000 162,210,000 118,534,000 103,624,000 97,157,000 85,303,000 69,813,000 63,561,000 54,600,000 71,881,000 60,906,000 54,324,000 85,966,000 64,916,000 54,645,000 53,434,000 12,090,397 10,231,475 8,361,452 8,361,138 
  commitments and contingencies                      
  stockholders' equity:                      
  common stock – class a shares, par value 0.0001, 2,750,000,000 shares authorized and 217,381,434 and 212,459,586 shares issued and outstanding as of june 30, 2025 and december 31, 2024, respectively; class v shares, par value 0.0001, 10,000,000 shares authorized and 8,377,623 shares issued and outstanding as of june 30, 2025 and december 31, 202423,000                      
  additional paid-in capital711,998,000 742,055,000 719,155,000 707,962,000 705,862,000 701,670,000 712,307,000 698,094,000 682,161,000 667,531,000 656,626,000 645,109,000 634,388,000 623,220,000 613,687,000 602,975,000 524,924,000 515,216,000 6,901,127 4,861,657 2,604,910 2,518,131 
  accumulated other comprehensive income822,000   229,000                   
  accumulated deficit-150,147,000 -192,652,000 -242,137,000 -268,162,000 -343,750,000 -357,047,000 -368,175,000 -369,420,000 -361,853,000 -354,696,000 -344,629,000 -333,722,000 -314,882,000 -295,203,000 -278,951,000 -247,790,000 -231,849,000 -222,696,000     
  total stockholders' equity562,696,000 549,261,000 476,716,000 440,051,000 361,966,000 344,482,000 344,029,000 328,562,000 320,071,000 312,745,000 311,741,000 310,946,000 319,059,000 327,715,000 334,619,000 355,153,000 293,054,000 292,466,000     
  total liabilities and stockholders' equity1,877,582,000 891,711,000 707,539,000 602,261,000 480,500,000 448,106,000 441,186,000 413,865,000 389,884,000 376,306,000 366,341,000 382,827,000 379,965,000 382,039,000         
  common stock – class a shares, par value 0.0001, 2,750,000,000 shares authorized and 215,206,274 and 212,459,586 shares issued and outstanding as of march 31, 2025 and december 31, 2024, respectively; class v shares, par value 0.0001, 10,000,000 shares authorized and 8,377,623 shares issued and outstanding as of march 31, 2025 and december 31, 2024 22,000                     
  accumulated other comprehensive loss -164,000 -324,000  -168,000 -162,000 -124,000 -133,000 -258,000 -111,000 -277,000 -462,000 -468,000 -323,000 -137,000 -52,000 -40,000 -72,000     
  earn-out payable     7,412,000 7,412,000     12,972,000 12,972,000 12,972,000 42,834,000        
  common stock – class a shares, par value 0.0001, 2,750,000,000 shares authorized and 212,459,586 and 205,104,120 shares issued and outstanding as of december 31, 2024 and 2023, respectively; class v shares, par value 0.0001, 10,000,000 shares authorized and 8,377,623 shares issued and outstanding as of december 31, 2024 and 2023  22,000                    
  common stock – class a shares, par value 0.0001, 2,750,000,000 shares authorized and 209,438,554 and 205,104,120 shares issued and outstanding as of september 30, 2024 and december 31, 2023, respectively; class v shares, par value 0.0001, 10,000,000 shares authorized and 8,377,623 shares issued and outstanding as of september 30, 2024 and december 31, 2023   22,000                   
  common stock – class a shares, par value 0.0001, 2,750,000,000 shares authorized and 208,417,651 and 205,104,120 shares issued and outstanding as of june 30, 2024 and december 31, 2023, respectively; class v shares, par value 0.0001, 10,000,000 shares authorized and 8,377,623 shares issued and outstanding as of june 30, 2024 and december 31, 2023    22,000                  
  common stock – class a shares, par value 0.0001, 2,750,000,000 shares authorized and 206,033,630 and 205,104,120 shares issued and outstanding as of march 31, 2024 and december 31, 2023, respectively; class v shares, par value 0.0001, 10,000,000 shares authorized and 8,377,623 shares issued and outstanding as of march 31, 2024 and december 31, 2023     21,000                 
  earn-out liabilities       6,862,000 4,776,000 3,977,000 2,975,000 739,000 1,510,000 1,544,000 1,999,000 23,205,000       
  common stock – class a shares, par value 0.0001, 2,750,000,000 shares authorized and 205,104,120 and 200,051,689 shares issued and outstanding as of december 31, 2023 and 2022, respectively; class v shares, par value 0.0001, 10,000,000 shares authorized and 8,377,623 shares issued and outstanding as of december 31, 2023 and 2022      21,000                
  intangibles       19,297,000 19,962,000 20,909,000 21,841,000 22,090,000 23,806,000 24,848,000 25,890,000 26,932,000       
  common stock – class a shares, par value 0.0001, 2,750,000,000 shares authorized and 203,578,394 and 200,051,689 shares issued and outstanding as of september 30, 2023 and december 31, 2022, respectively; class v shares, par value 0.0001, 10,000,000 shares authorized and 8,377,623 shares issued and outstanding as of september 30, 2023 and december 31, 2022       21,000               
  common stock – class a shares, par value 0.0001, 2,750,000,000 shares authorized and 202,419,498 and 200,051,689 shares issued and outstanding as of june 30, 2023 and december 31, 2022, respectively; class v shares, par value 0.0001, 10,000,000 shares authorized and 8,377,623 shares issued and outstanding as of june 30, 2023 and december 31, 2022        21,000              
  common stock – class a shares, par value 0.0001, 2,750,000,000 shares authorized and 200,934,421 and 200,051,689 shares issued and outstanding as of march 31, 2023 and december 31, 2022, respectively; class v shares, par value 0.0001, 10,000,000 shares authorized and 8,377,623 shares issued and outstanding as of march 31, 2023 and december 31, 2022         21,000             
  common stock – class a shares, par value 0.0001, 2,750,000,000 shares authorized and 200,051,689 and 196,414,363 shares issued and outstanding as of december 31, 2022 and 2021, respectively; class v shares, par value 0.0001, 10,000,000 shares authorized and 8,377,623 shares issued and outstanding as of december 31, 2022 and 2021          21,000            
  common stock – class a shares, par value 0.0001, 2,750,000,000 shares authorized and 199,309,580 and 196,414,363 shares issued and outstanding as of september 30, 2022 and december 31, 2021, respectively; class v shares, par value 0.0001, 10,000,000 shares authorized and 8,377,623 shares issued and outstanding as of september 30, 2022 and december 31, 2021           21,000           
  common stock – class a shares, par value 0.0001, 2,750,000,000 shares authorized and 198,472,604 and 196,414,363 shares issued and outstanding as of june 30, 2022 and december 31, 2021, respectively; class v shares, par value 0.0001, 10,000,000 shares authorized and 8,377,623 shares issued and outstanding as of june 30, 2022 and december 31, 2021            21,000          
  common stock – class a shares, par value 0.0001, 2,750,000,000 shares authorized and 197,503,386 and 196,414,363 shares issued and outstanding as of march 31, 2022 and december 31, 2021, respectively; class v shares, par value 0.0001, 10,000,000 shares authorized and 8,377,623 shares issued and outstanding as of march 31, 2022 and december 31, 2021             21,000         
  deferred transaction costs                      
  liabilities, mezzanine equity, and stockholders' equity                      
  warrant liabilities                      
  mezzanine equity:                      
  redeemable convertible preferred stock                      
  total mezzanine equity                      
  stockholders' equity                      
  common stock – class a shares, par value 0.0001, 2,750,000,000 and 166,696,759 shares authorized and 196,414,363 and 46,025,754 shares issued and outstanding as of december 31, 2021 and december 31, 2020, respectively; class v shares, par value 0.0001, 10,000,000 shares authorized and 8,377,623 shares issued and outstanding as of december 31, 2021; class f shares, par value 0.0001, 6,941,352 shares authorized, issued, and outstanding as of december 31, 2020              20,000        
  total liabilities, mezzanine equity, and stockholders' equity              420,585,000 420,069,000 347,699,000 345,900,000     
  common stock – class a shares, par value 0.0001, 2,750,000,000 and 166,696,759 shares authorized and 195,439,626 and 46,025,754 shares issued and outstanding as of september 30, 2021 and december 31, 2020, respectively; class v shares, par value 0.0001, 10,000,000 shares authorized and 8,377,623 shares issued and outstanding as of september 30, 2021; class f shares, par value 0.0001, 6,941,352 shares authorized, issued, and outstanding as of december 31, 2020               20,000       
  common stock – class a shares, par value 0.0001, 2,750,000,000 and 166,696,759 shares authorized and 184,866,219 and 46,025,754 shares issued and outstanding as of june 30, 2021 and december 31, 2020, respectively; class v shares, par value 0.0001, 10,000,000 shares authorized and 8,377,623 shares issued and outstanding as of june 30, 2021; class f shares, par value 0.0001, 6,941,352 shares authorized, issued, and outstanding as of december 31, 2020                19,000      
  restricted cash, noncurrent                 856,000     
  deferred rent, noncurrent                 384,000     
  common stock – class a shares, par value 0.0001, 2,750,000,000 and 166,696,759 shares authorized and 182,973,780 and 46,025,754 shares issued and outstanding as of march 31, 2021 and december 31, 2020, respectively; class v shares, par value 0.0001, 10,000,000 shares authorized and 8,377,623 shares issued, and outstanding as of march 31, 2021; class f shares, par value 0.0001, 6,941,352 shares authorized, issued, and outstanding as of december 31, 2020                 18,000     
  prepaid expenses                  50,100 75,150 90,200 117,350 
  investments held in trust account                  204,525,055 204,481,237 204,725,005 204,688,147 
  liabilities and shareholders’ equity                      
  accrued expenses                  4,189,620 2,579,005 535,852 558,617 
  accrued expenses – related party                  60,000    
  due to related parties                  598,833 404,007 495,355 449,378 
  deferred underwriting commissions                  7,043,750 7,043,750 7,043,750 7,043,750 
  deferred legal fees                  150,000 150,000 150,000 150,000 
  class a ordinary shares, 0.0001 par value; 500,000,000 shares authorized, 18,854,302 and 19,159,203 shares subject to possible redemption at 10.00 per share as of december 31, 2020 and 2019, respectively                  188,543,020    
  shareholders’ equity:                      
  preference shares, 0.0001 par value; 1,000,000 shares authorized; none issued and outstanding                      
  class a ordinary shares, 0.0001 par value; 500,000,000 shares authorized; 1,270,698 and 965,797 shares issued and outstanding (excluding 18,854,302 and 19,159,203 shares subject to possible redemption) as of december 31, 2020 and 2019, respectively                  127    
  class b ordinary shares, 0.0001 par value; 50,000,000 shares authorized; 5,031,250 shares issued and outstanding as of december 31, 2020 and 2019                  503    
  (accumulated deficit) retained earnings                  -1,901,752    
  total shareholders’ equity                  5,000,005 5,000,003 5,000,005 5,000,001 
  total liabilities and shareholders’ equity                  205,633,422 205,813,988 206,200,737 206,287,199 
  accrued expenses—related party                   30,000   
  class a ordinary shares, 0.0001 par value; 500,000,000 shares authorized, 19,058,251 and 19,159,203 shares subject to possible redemption at 10.00 per share as of september 30, 2020 and december 31, 2019, respectively                   190,582,510   
  class a ordinary shares, 0.0001 par value; 500,000,000 shares authorized; 1,066,749 and 965,797 shares issued and outstanding (excluding 19,058,251 and 19,159,203 shares subject to possible redemption) as of september 30, 2020 and december 31, 2019, respectively                   107   
  class b ordinary shares, 0.0001 par value; 50,000,000 shares authorized; 5,031,250 shares issued and outstanding as of september 30, 2020 and december 31, 2019                   503   
  retained earnings                   137,736 2,394,508 2,481,284 
  cash                    1,385,532 1,481,702 
  accrued expenses - related party                    114,839 84,839 
  class a ordinary shares, 0.0001 par value; 500,000,000 shares authorized, 19,283,928 and 19,159,203 shares subject to possible redemption at 10.00 per share as of june 30, 2020 and december 31, 2019, respectively                    192,839,280  
  class a ordinary shares, 0.0001 par value; 500,000,000 shares authorized; 841,072 and 965,797 shares issued and outstanding (excluding 19,283,928 and 19,159,203 shares subject to possible redemption) as of june 30, 2020 and december 31, 2019, respectively                    84  
  class b ordinary shares, 0.0001 par value; 50,000,000 shares authorized; 5,031,250 shares issued and outstanding as of june 30, 2020 and december 31, 2019                    503  
  class a ordinary shares, 0.0001 par value; 500,000,000 shares authorized, 19,292,606 and 19,159,203 shares subject to possible redemption at 10.00 per share as of march 31, 2020 and december 31, 2019, respectively                     192,926,060 
  class a ordinary shares, 0.0001 par value; 500,000,000 shares authorized; 832,394 and 965,797 shares issued and outstanding (excluding 19,292,606 and 19,159,203 shares subject to possible redemption) as of march 31, 2020 and december 31, 2019, respectively                     83 
  class b ordinary shares, 0.0001 par value; 50,000,000 shares authorized; 5,031,250 shares issued and outstanding as of march 31, 2020 and december 31, 2019                     503 

We provide you with 20 years of balance sheets for Hims & Hers Health stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Hims & Hers Health. Explore the full financial landscape of Hims & Hers Health stock with our expertly curated balance sheets.

The information provided in this report about Hims & Hers Health stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.